ARUP's Laboratory Test Directory

Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication : 2003172
[ image for: Patient History for CCM]
Patient History for CCM
  


Mnemonic: CCM DELDUP

Methodology: Polymerase Chain Reaction/Multiplex Ligation-dependent Probe Amplification
Performed: Varies
Reported: Within 21 days
Specimen Required: Collect: Lavender (EDTA), pink (K2EDTA), or yellow (ACD Solution A or B).

Specimen Preparation: Transport 3 mL whole blood. (Min: 1 mL)

Storage/Transport Temperature: Refrigerated.

Stability (collection to initiation of testing): Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable

Interpretive Data: Background Information for Cerebral Cavernous Malformation (CCM1, CCM2, and CCM3) Deletion/Duplication:
Characteristics of Cerebral Cavernous Malformation (CCM):
Seizures, focal neurologic deficits, nonspecific headaches, and cerebral hemorrhage.
Incidence of Familial CCM:
1:2,000 to 1:10,000.
Inheritance:
Autosomal dominant.
Cause:
Pathogenic mutations in the KRIT1 (CCM1), CCM2, PDCD10 (CCM3), and unknown gene(s).
Genes Tested:
KRIT1 (CCM1), CCM2, PDCD10 (CCM3).
Clinical Sensitivity:
20-25 percent for KRIT1 (CCM1), CCM2, and PDCD10 (CCM3) combined.
Methodology:
Multiplex ligation-dependent probe amplification (MLPA) of the entire KRIT1 (CCM1), CCM2, and PDCD10 (CCM3) coding regions, with the exception of exon 7 of KRIT1 (CCM1).
Analytical Sensitivity and Specificity of MLPA:
90 and 99 percent, respectively.
Limitations
: Rare diagnostic errors can occur due to probe site mutations. Single base pair substitutions, small deletions/duplications, regulatory region mutations, and deep intronic mutations will not be detected. Deletion/duplication breakpoints will not be determined. Deletions and duplications of KRIT1 (CCM1) exon 7 will not be detected.



Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

Refer to Statement C under Testing Information at http://www.aruplab.com.
CPT Code(s): 83891 Isolation; 83896 x2 Nucleic Acid Probes; 83898 x2 Amplification; 83914 x2 Extension; 83909 x2 Capillary Electrophoresis; 83912 Interpretation and report - Additional CPT code modifiers may be required for procedures performed to test for oncologic or  inherited disorders.
Cross References: CCM1 (Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication) , CCM2 (Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication) , CCM3 (Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication) , Cerebral Cavernous Angioma (Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication) , KRIT1 (Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication) , MGC4607 (Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication) , PDCD10 (Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication)
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org